• 1
    Fox PR. Feline cardiomyopathies. In: FoxPR, SissonD, MoiseNS, eds. Textbook of Canine and Feline Cardiology, 2nd ed. Philadelphia, PA: WB Saunders; 1999:621678.
  • 2
    Kittleson MD. Feline myocardial disease. In: EttingerSJ, FeldmanEC, eds. Textbook of Veterinary Internal Medicine, 6th ed. St Louis, MO: Elsevier; 2005:10821104.
  • 3
    Rush JE. Therapy of feline hypertrophic cardiomyopathy. Vet Clin North Am Small Anim Pract 1998;28:14591479.
  • 4
    Cote E, Manning AM, Emerson D, et al. Assessment of the prevalence of heart murmurs in overtly healthy cats. J Am Vet Med Assoc 2004;225:384388.
  • 5
    Paige CF, Abbott JA, Elvinger F, Pyle RL. Prevalence of cardiomyopathy in apparently healthy cats. J Am Vet Med Assoc 2009;234:13981403.
  • 6
    Pion PD, Kittleson MD, Rogers QR, Morris JG. Myocardial failure in cats associated with low plasma taurine: A reversible cardiomyopathy. Science 1987;237:764768.
  • 7
    McMichael MA, Freeman LM, Selhub J, et al. Plasma homocysteine, B vitamins, and amino acid concentrations in cats with cardiomyopathy and arterial thromboembolism. J Vet Intern Med 2000;14:507512.
  • 8
    Freeman LM. Nutritional management of heart disease. In: BonaguraJD, TwedtDC, eds. Current Veterinary Therapy XIV. St Louis, MO: Elsevier; 2009:704708.
  • 9
    Freeman LM, Rush JE, Kehayias JJ, et al. Nutritional alterations and the effect of fish oil supplementation in dogs with heart failure. J Vet Intern Med 1998;12:440448.
  • 10
    Smith CE, Freeman LM, Rush JE, et al. Omega-3 fatty acids in Boxer dogs with arrhythmogenic right ventricular cardiomyopathy. J Vet Intern Med 2007;21:265273.
  • 11
    Freeman LM, Rush JE, Markwell PJ. Effects of dietary modification in dogs with early chronic valvular disease. J Vet Intern Med 2006;20:11161126.
  • 12
    Freeman LM, Rush JE. Relationship between cachexia and lymphocyte subpopulations and hematologic parameters in dogs with spontaneously-occurring congestive heart failure. Proceedings of Third Cachexia Conference, Rome, Italy. December 8–10, 2005: 82.
  • 13
    Anker SD, Ponikowski P, Varney S, et al. Wasting as an independent risk factor for mortality in chronic heart failure. Lancet 1997;349:10501053.
  • 14
    Anker SD, Negassa A, Coats AJ, et al. Prognostic importance of weight loss in chronic heart failure and the effect of treatment with angiotensin-converting-enzyme inhibitors: An observational study. Lancet 2003;361:10771083.
  • 15
    Freeman L, Roubenoff R. Nutrition implications of cardiac cachexia. Nutr Rev 1994;52:340347.
  • 16
    Freeman LM. The pathophysiology of cardiac cachexia. Curr Opin Support Palliat Care 2009;3:276281.
  • 17
    Von Haehling S, Lainscak M, Springer J, Anker SD. Cardiac cachexia: A systematic overview. Pharm Ther 2009;121:227252.
  • 18
    Allan FJ, Pfeiffer DU, Jones BR, et al. A cross-sectional study of risk factors for obesity in cats in New Zealand. Prev Vet Med 2000;46:183196.
  • 19
    Russell K, Sabin R, Holt S, et al. Influence of feeding regimen on body condition in the cat. J Small Anim Pract 2000;41:1217.
  • 20
    Lund EM, Armstrong PJ, Kirk CA, Klausner JS. Prevalence and risk factors for obesity in adult cats from private US veterinary practices. Intern J Appl Res Vet Med 2005;3:8897.
  • 21
    Yang VK, Freeman LM, Rush JE. Morphometric measurements and insulin-like growth factor in normal cats and cats with hypertrophic cardiomyopathy. Am J Vet Res 2008;69:10611066.
  • 22
    Horwich TB, Fonarow GC, Hamilton MA, et al. The relationship between obesity and mortality in patients with heart failure. J Am Coll Cardiol 2001;38:789795.
  • 23
    Davos CH, Dowhner W, Rauchhaus M, et al. Body mass and survival in patients with chronic heart failure without cachexia: The importance of obesity. J Cardiac Fail 2003;9:2935.
  • 24
    Lavie CJ, Osman AF, Milani RV, Mehra MR. Body composition and prognosis in chronic systolic heart failure: The obesity paradox. Am J Cardiol 2003;91:891894.
  • 25
    Bozkurt B, Deswal A. Obesity as a prognostic factor in chronic symptomatic heart failure. Am Heart J 2005;150:12331239.
  • 26
    Butler J, Howser R, Portner PM, Pierson RN III. Body mass index and outcomes after left ventricular assist device placement. Ann Thorac Surg 2005;79:6673.
  • 27
    Curtis JP, Selter JG, Wang Y, et al. The obesity paradox: Body mass index and outcomes in patients with heart failure. Arch Intern Med 2005;165:5561.
  • 28
    Gustafsson F, Kragelund CB, Torp-Pedersen C, et al. Effect of obesity and being overweight on long-term mortality in congestive heart failure: Influence of left ventricular function. Eur Heart J 2005;26:5864.
  • 29
    Hall J, French TK, Rasmusson KD, et al. The paradox of obesity in patients with heart failure. J Am Acad Nurse Pract 2005;17:542546.
  • 30
    Kristorp C, Faber J, Galatius S, et al. Plasma adiponectin, body mass index, and mortality in patients with chronic heart failure. Circulation 2005;112:17561762.
  • 31
    Cicoira M, Maggioni AP, Latini R, et al. Body mass index, prognosis and mode of death in chronic heart failure: Results from the Valsartan Heart Failure Trial. Eur J Heart Fail 2007;9:397402.
  • 32
    Fonorow GC, Srikanthan P, Costanzo MR, et al. An obesity paradox in acute heart failure: Analysis of body mass index and inhospital mortality for 108,927 patients in the Acute Decompensated Heart Failure National Registry. Am Heart J 2007;153:7481.
  • 33
    Kenchaiah S, Pocock SJ, Wang D, et al. Body mass index and prognosis in patients with chronic heart failure: Insights from the Candesartan in Heart Failure: Assessment of Reduction in Mortality and morbidity (CHARM) Program. Circulation 2007;116:627636.
  • 34
    Abdulla J, Kober L, Abildstrom SZ, et al. Impact of obesity as a mortality predictor in high-risk patients with myocardial infarction or chronic heart failure: A pooled analysis of five registries. Eur Heart J 2008;29:594601.
  • 35
    Oreopoulos A, Padwal R, Kalantar-Zadeh K, et al. Body mass index and mortality in heart failure: A meta-analysis. Am Heart J 2008;156:1322.
  • 36
    Slupe JL, Freeman LM, Rush JE. Association of body weight and body condition with survival in dogs with heart failure. J Vet Intern Med 2008;22:561565.
  • 37
    Arena R, Myers J, Abella J, et al. Influence of etiology of heart failure on the obesity paradox. Am J Cardiol 2009;104:11161121.
  • 38
    Kapoor JR, Heidenreich RA. Obesity and survival in patients with heart failure and preserved systolic function: A U-shaped relationship. Am Heart J 2010;159:7580.
  • 39
    Webster J, Hesp R, Garrow J. The composition of excess weight in obese women estimated by body density, total body water and total body potassium. Hum Nutr Clin Nutr 1984;38:299306.
  • 40
    Wells JCK, Rewtrell MS, Williams JE, et al. Body composition in normal weight, overweight and obese children: Matched case-control analyses of total and regional tissue masses, and body composition trends in relation to relative weight. Intl J Obesity 2006;30:15061513.
  • 41
    Laflamme DP. Development and validation of a body condition score system for cats. Feline Pract 1997;25:1318.
  • 42
    Therneau TM, Grambsch PM, Fleming TR. Martingale-based residuals and survival models. Biometrika 1990;77:147160.
  • 43
    Musci M, Loforte A, Potapov EV, et al. Body mass index and outcome after ventricular assist device placement. Ann Thorac Surg 2008;86:12361242.
  • 44
    Baez JL, Michel KE, Sorenmo K, Shofer FS. A prospective investigation of the prevalence and prognostic significance of weight loss and changes in body condition in feline cancer patients. J Feline Med Surg 2007;9:411417.
  • 45
    Mallery KF, Freeman LM, Harpster NK, Rush JE. Factors contributing to the euthanasia decision in dogs with congestive heart failure. J Am Vet Med Assoc 1999;214:12011204.